Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial DiseasesAlida L.P. Caforio, Perry Elliott, Arsen Ristić et al.|European Heart Journal|2013Cited by 3.4k
2023 ESC Guidelines for the management of cardiomyopathiesElena Arbelo, Ulf Landmesser, Alexandros Protonotarios et al.|European Heart Journal|2023Cited by 2.3k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trialIacopo Olivotto, Amos Katz, Artur Oręziak et al.|The Lancet|2020Cited by 1.2k
Risk Factors for Malignant Ventricular Arrhythmias in Lamin A/C Mutation CarriersIngrid A.W. van Rijsingen, Yigal M. Pinto, Eloisa Arbustini et al.|Journal of the American College of Cardiology|2012Cited by 519
Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids)Gabrielle Norrish, Juan Pablo Kaski, Tao Ding et al.|JAMA Cardiology|2019Cited by 248